PersonFounderExecutive
Michael Choukas
Michael Choukas is the co-founder and CEO of Autem Therapeutics, a Hanover, New Hampshire biotech building AutEMsys, a bioelectric platform that delivers personalized, amplitude-modulated electromagnetic frequencies to treat solid tumor cancers. A Dartmouth and Harvard Business School graduate, he spent two decades running clinical-development, real-world-data, and oncology-analytics businesses at firms like ConcertAI, Vector Oncology, United BioSource, SCIREX and Bain & Company, work he credits with more than $2.5 billion in market value creation. He raised a $10 million Series A-1 in 2022 and is steering Autem toward FDA-cleared trials in liver cancer and glioblastoma.
michael choukasautem therapeuticsceoco-founderbiotechoncology
